Arcus Biosciences, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-6500.0% -$130M
$-132M
Free Cash Flow↑+0.0% +$0
$-1M
Investing Cash Flow
$79M
Financing Cash Flow
$286M
Capex↑+0.0% +$0
$1M
Stock-Based Comp↓-11.8% -$2M
$15M
Debt Issued
$0
D&A↑+0.0% +$0
$3M
SBC Allocated Expense↓-11.8% -$2M
$15M